glp 1 antagonist drugs The GLP-1 Agonists and Obesity: How Diabetes are Changing Non-Diabetic Lives — tl;dr pharmacy Glucagon-like peptide-1 - Wikipedia
Description
doi: 10.1210/jc.2011-2407 209 AlvesCBatel-MarquesFMacedoAF
Approximately 15-40% of individuals diagnosed with IBD and an additional 20-40% are estimated to be obese and overweight respectively ( Table 1 )
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
When heterogeneity was obvious (I 2 50 %), a random-effects model was used to summarize the RRs
N., Vasas, S., Tsamandouras, N., & Birnbaum, M
Nausea can become a cycle: low appetite leads to low intake, low intake leads to weakness or queasiness, and then food feels even harder to tolerate
